GAIA is a leading company in digital health, focusing on the development of evidence-based, safe, and accessible digital therapeutics that aid patients in restoring and maintaining mental and physical health. With over 20 years of experience and more than 70 products, GAIA has demonstrated clinically proven effectiveness through over 19 randomized controlled trials and 2 meta-analyses. The company combines scientific, technological, and therapeutic expertise and collaborates with well-known pharmaceutical companies, health insurance providers, medical research organizations, and universities worldwide.

GAIA's mission is to develop digital therapeutics that match pharmaceutical solutions in effect size, safety, and convenience for physicians, therapists, payers, and patients. Their multidisciplinary team includes physicians, psychotherapists, clinical scientists, IT engineers, regulatory experts, and market access specialists. The company values rigorous scientific research evidenced by extensive randomized controlled trials for their products, such as the well-researched depression treatment program, deprexis®.

GAIA engages in numerous research and development projects spanning medical, psychological, and technological fields. They collaborate closely with leading scientists and institutions globally to innovate and optimize health interventions. Their research encompasses various conditions, including depression, anxiety, multiple sclerosis, and epilepsy, contributing to the scientific community with numerous publications.

GAIA offers a dynamic work environment blending startup creativity with the stability of an established company. Employees enjoy flexible work arrangements, including remote options, and a healthy work atmosphere promoting growth and innovation. The company provides modern office spaces, wellness amenities such as fresh fruit and drinks, and recreational options like a company-owned canoe.